3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Breast Neoplasms
51
Neoplasms
29
Prostatic Neoplasms
28
Head and Neck Neoplasms
15
Lung Neoplasms
14
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Urinary Bladder Neoplasms
6
Sarcoma
6
Oropharyngeal Neoplasms
6
Hematologic Neoplasms
6
Gastrointestinal Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Rectal Neoplasms
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Endometrial Neoplasms
5
Depression
5
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycystic Ovary Syndrome
4
Motor Activity
4
Melanoma
4
Lymphoma
4
Anxiety Disorders
4
Stomach Neoplasms
3
Pain
3
Osteosarcoma
3
Interventions
Nivolumab
4
Ipilimumab
3
Specimen Handling
2
Proton Therapy
2
Magnetic Resonance Spectroscopy
2
Cetuximab
2
tazemetostat
1
spartalizumab
1
pembrolizumab
1
nilotinib
1
atezolizumab
1
Zoledronic Acid
1
X-Rays
1
Tiragolumab
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiosurgery
1
Phantoms, Imaging
1
Imatinib Mesylate
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chordoma
×
Surveys and Questionnaires
×
1 year
×
Clear all
NCT06535997
2025-08-06
PRIMHADRON
Hospices Civils de Lyon
Completed
62 enrolled